Leucid Bio
Latest round
- Series A
Last raised
- Sep 2021
Total raised
- $21M
Investors
- 5
About Leucid Bio
Founded in 2014, Leucid Bio Ltd operates from London, UK, specializing in CAR-T therapies. The company has undergone strategic developments, including a significant focus on its lead candidate, LEU011, targeting various cancers.Leucid Bio specializes in the development of advanced CAR-T therapies, primarily leveraging its proprietary Lateral CAR platform, designed to enhance the efficacy and safety of T-cell therapies. The flagship product, LEU011, is an autologous CAR-T therapy targeting NKG2D stress ligands, prevalent in over 80% of human tumor cells, making it applicable for various cancers. John Maher at King's College London, focuses on reprogramming T-cells to effectively eliminate cancer cells.Leucid Bio generates revenue through partnerships and collaborations with healthcare institutions that administer specialized cancer therapies. Revenue streams typically involve the provision of LEU011 and other products to clinical trial sites and healthcare providers. The company aims to expand its market presence primarily across North America and Europe, leveraging its innovative treatment strategies to address unmet medical needs in oncology.
Who invested in Leucid Bio
5 investors across 3 rounds
See all investors in Leucid Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Leucid Bio
Who invested in Leucid Bio?
Leucid Bio has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Leucid Bio raised?
Leucid Bio has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Leucid Bio last raise money?
Leucid Bio's most recent round on record is a Series A, in Sep 2021.
What does Leucid Bio do?
Founded in 2014, Leucid Bio Ltd operates from London, UK, specializing in CAR-T therapies.
Where is Leucid Bio headquartered?
Leucid Bio is headquartered in London, UK.
Which VCs invest in companies like Leucid Bio?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Leucid Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Leucid Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.